Results 191 to 200 of about 18,928 (273)

Low‐Barrier Fibrosis Screening in Hepatitis C Treatment: The Decompensated Cirrhosis in Hepatitis C Evaluation Questionnaire

open access: yesJournal of Viral Hepatitis, Volume 33, Issue 6, June 2026.
ABSTRACT Achieving hepatitis C virus (HCV) elimination requires innovative paradigms that overcome barriers to treatment, such as requiring pre‐treatment elastography or phlebotomy‐based fibrosis assessment. To identify patients at low risk of advanced fibrosis or decompensated cirrhosis within our HCV treatment programme, we developed and ...
Hunter Spencer   +4 more
wiley   +1 more source

Diagnostic accuracy of transient elastography in MASLD is independent of MRI-PDFF steatosis in a multicenter study. [PDF]

open access: yesJHEP Rep
Masrour O   +14 more
europepmc   +1 more source

Real‐World Outcomes of Opti‐Hep‐D: An Innovative, Multicentre and Multidisciplinary Program Improving Hepatitis D Cascade of Care

open access: yesLiver International, Volume 46, Issue 6, June 2026.
ABSTRACT Background and Aim Hepatitis D virus (HDV) infection remains underdiagnosed, and real‐world data on screening and linkage to care are limited. We assessed the implementation of Opti‐Hep‐D, a publicly funded initiative for HDV management in the Spanish region of Catalonia.
Adriana Palom   +20 more
wiley   +1 more source

Liver Stiffness Measured by Vibration-Controlled Transient Elastography Predicts Hepatic Decompensation in Patients with Hepatocellular Carcinoma Receiving Systemic Treatments. [PDF]

open access: yesLiver Cancer
Lee J   +20 more
europepmc   +1 more source

A comparison of plasma Tsukushi in adolescents with and without metabolic dysfunction‐associated steatotic liver disease

open access: yesPhysiological Reports, Volume 14, Issue 12, June 2026.
Abstract Metabolic dysfunction‐associated steatotic liver disease (MASLD) is the most common liver disease in children and adolescents. Assessment of circulating biomarkers is needed to understand the underlying pathology, disease severity, and treatment options.
Sydni A. McNeese   +6 more
wiley   +1 more source

Cost-effectiveness of transient elastography for liver fibrosis screening in Thai patients with diabetes mellitus. [PDF]

open access: yesWorld J Gastroenterol
Kositamongkol C   +7 more
europepmc   +1 more source

Assessment of liver and spleen stiffness and hepatic steatosis by transient elastography (Fibroscan®) in type 1 Gaucher disease: a single center case-control cohort study. [PDF]

open access: yesOrphanet J Rare Dis
Mutlu U   +8 more
europepmc   +1 more source

Transient elastography and fibrosis-4 index as predictors of hepatocellular carcinoma in hepatitis C virus patients with sustained virological response. [PDF]

open access: yesWorld J Gastroenterol
da Silva PGF   +10 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy